# Baxter Healthcare Corporation – FDA Inspection, Nov 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/cef89742-403b-4ca4-ba82-a971114ca49d
Source feed: FDA_Inspections

> FDA inspection 1223749 of Baxter Healthcare Corporation, November 29, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223749
- Company Name: Baxter Healthcare Corporation
- Inspection Date: 2023-11-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1337134 - 2026-09-23](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c638b85a-360f-4e29-97e5-0c4c0d759d95)
- [FDA Inspection 1224107 - 2023-11-15](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/703e2ccc-7a22-4bf7-af34-cce008b85997)
- [FDA Inspection 1064657 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/8b50c13e-e13a-45cd-950d-ef3cbef29a32)
- [FDA Inspection 937961 - 2015-06-08](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/b1b0ef30-15e0-466d-bea4-386df55ab688)
- [FDA Inspection 879690 - 2014-05-12](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/050f2d8a-282e-46c5-ae42-82d6e165cd40)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/ariel-cruz-figueroa/c6ade050-dbe1-4aa3-b88f-980db51b88b0)
- [Issuing Officer](https://www.keypedia.com/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce)

Company: https://www.keypedia.com/companies/baxter-healthcare-corporation/37ed59ef-c570-47ec-8477-ca9c766cac29

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
